Blood-glucose-reducing Mulgedium tataricum tea and preparation method thereof

Abstract

The invention discloses blood-glucose-reducing Mulgedium tataricum tea and a preparation method thereof, belonging to technical field of preparation of health tea drink. The blood-glucose-reducing Mulgedium tataricum tea is prepared from 1-3 parts of Mulgedium tataricum, 1-3 parts of corn stigma and 1-3 parts of lotus leaf through drying, mixing, crushing and sieving. The preparation method comprises the following steps: (1) taking 1-3 parts by mass of Mulgedium tataricum, 1-3 parts by mass of corn stigma and 1-3 parts by mass of lotus leaf; and (2) drying the raw materials in the step (1), mixing, crushing, sieving by a 40-mesh screen, packaging into bags, and sterilizing to prepare the blood-glucose-reducing Mulgedium tataricum tea. According to the blood-glucose-reducing Mulgedium tataricum tea, the inhibition activity of alpha-glucosidase of Mulgedium tataricum is used as a main function for reducing blood glucose, the diuresis-promoting, heat-clearing and choleretic effects of corn stigma and the heat-clearing, lipid-lowering and anti-oxidation functions of the lotus leaf are combined, the postprandial blood glucose value can be reduced, the diabetic ketoacidosis risk is avoided, and the damage of diabetic complication to a human body can be prevented. The preparation method has simple operation steps, has low equipment requirements and is favorable for large-scale production.

Description

technical field [0001] The invention belongs to the technical field of preparation of health-care tea drinks, and in particular relates to a tea with milk lettuce for reducing blood sugar and a preparation method thereof. Background technique [0002] Diabetes mellitus is a frequently-occurring disease with a high incidence rate. The etiology is complex and the course of the disease is long. It can cause various complications and seriously affect the quality of life of patients. At present, the number of diabetic patients in my country, especially type Ⅱ diabetes patients, is increasing year by year. Globally, its fatality rate ranks third after tumors and cardiovascular diseases. [0003] For a long time, blood sugar monitoring in the treatment of diabetes has often only paid attention to fasting blood sugar and ignored postprandial blood sugar. However, recent studies have found that postprandial hyperglycemia often occurs first in the onset of diabetes, and then develops...

AI Technical Summary

Problems solved by technology

[0007] At present, the drugs used to treat diabetes are mainly chemical synthetic drugs. However, it has been clinically verified that although chemical synthetic drugs have significant short-term curative effects, they often have side effects of varying degrees, such as hypoglycemia, weight gain, cardiovascular disease, etc., and are not suitable for long-term use.

Images